245 related articles for article (PubMed ID: 19047051)
21. Defining an allosteric circuit in the cysteine protease domain of Clostridium difficile toxins.
Shen A; Lupardus PJ; Gersch MM; Puri AW; Albrow VE; Garcia KC; Bogyo M
Nat Struct Mol Biol; 2011 Mar; 18(3):364-71. PubMed ID: 21317893
[TBL] [Abstract][Full Text] [Related]
22. Cellular uptake of Clostridium difficile toxin B. Translocation of the N-terminal catalytic domain into the cytosol of eukaryotic cells.
Pfeifer G; Schirmer J; Leemhuis J; Busch C; Meyer DK; Aktories K; Barth H
J Biol Chem; 2003 Nov; 278(45):44535-41. PubMed ID: 12941936
[TBL] [Abstract][Full Text] [Related]
23. Analysis of TcdB Proteins within the Hypervirulent Clade 2 Reveals an Impact of RhoA Glucosylation on Clostridium difficile Proinflammatory Activities.
Quesada-Gómez C; López-Ureña D; Chumbler N; Kroh HK; Castro-Peña C; Rodríguez C; Orozco-Aguilar J; González-Camacho S; Rucavado A; Guzmán-Verri C; Lawley TD; Lacy DB; Chaves-Olarte E
Infect Immun; 2016 Jan; 84(3):856-65. PubMed ID: 26755157
[TBL] [Abstract][Full Text] [Related]
24. Processing of Clostridium difficile toxins.
Giesemann T; Egerer M; Jank T; Aktories K
J Med Microbiol; 2008 Jun; 57(Pt 6):690-696. PubMed ID: 18480324
[TBL] [Abstract][Full Text] [Related]
25. Structure-function analysis of inositol hexakisphosphate-induced autoprocessing of the Vibrio cholerae multifunctional autoprocessing RTX toxin.
Prochazkova K; Satchell KJ
J Biol Chem; 2008 Aug; 283(35):23656-64. PubMed ID: 18591243
[TBL] [Abstract][Full Text] [Related]
26. Characterization of the cleavage site and function of resulting cleavage fragments after limited proteolysis of Clostridium difficile toxin B (TcdB) by host cells.
Rupnik M; Pabst S; Rupnik M; von Eichel-Streiber C; Urlaub H; Söling HD
Microbiology (Reading); 2005 Jan; 151(Pt 1):199-208. PubMed ID: 15632438
[TBL] [Abstract][Full Text] [Related]
27. Clonal spread of a Clostridium difficile strain with a complete set of toxin A, toxin B, and binary toxin genes among Polish patients with Clostridium difficile-associated diarrhea.
Pituch H; Kreft D; Obuch-Woszczatynski P; Wultańska D; Meisel-Mikołajczyk F; Łuczak M; van Belkum A
J Clin Microbiol; 2005 Jan; 43(1):472-5. PubMed ID: 15635019
[TBL] [Abstract][Full Text] [Related]
28. The enzymatic domain of Clostridium difficile toxin A is located within its N-terminal region.
Faust C; Ye B; Song KP
Biochem Biophys Res Commun; 1998 Oct; 251(1):100-5. PubMed ID: 9790914
[TBL] [Abstract][Full Text] [Related]
29. Super toxins from a super bug: structure and function of Clostridium difficile toxins.
Davies AH; Roberts AK; Shone CC; Acharya KR
Biochem J; 2011 Jun; 436(3):517-26. PubMed ID: 21615333
[TBL] [Abstract][Full Text] [Related]
30. Structural determinants for membrane insertion, pore formation and translocation of Clostridium difficile toxin B.
Genisyuerek S; Papatheodorou P; Guttenberg G; Schubert R; Benz R; Aktories K
Mol Microbiol; 2011 Mar; 79(6):1643-54. PubMed ID: 21231971
[TBL] [Abstract][Full Text] [Related]
31. The Role of Rho GTPases in Toxicity of Clostridium difficile Toxins.
Chen S; Sun C; Wang H; Wang J
Toxins (Basel); 2015 Dec; 7(12):5254-67. PubMed ID: 26633511
[TBL] [Abstract][Full Text] [Related]
32. The glucosyltransferase activity of C. difficile Toxin B is required for disease pathogenesis.
Bilverstone TW; Garland M; Cave RJ; Kelly ML; Tholen M; Bouley DM; Kaye P; Minton NP; Bogyo M; Kuehne SA; Melnyk RA
PLoS Pathog; 2020 Sep; 16(9):e1008852. PubMed ID: 32960931
[TBL] [Abstract][Full Text] [Related]
33. Toxin B is essential for virulence of Clostridium difficile.
Lyras D; O'Connor JR; Howarth PM; Sambol SP; Carter GP; Phumoonna T; Poon R; Adams V; Vedantam G; Johnson S; Gerding DN; Rood JI
Nature; 2009 Apr; 458(7242):1176-9. PubMed ID: 19252482
[TBL] [Abstract][Full Text] [Related]
34. Both, toxin A and toxin B, are important in Clostridium difficile infection.
Kuehne SA; Cartman ST; Minton NP
Gut Microbes; 2011; 2(4):252-5. PubMed ID: 21804353
[TBL] [Abstract][Full Text] [Related]
35. Structure and mode of action of clostridial glucosylating toxins: the ABCD model.
Jank T; Aktories K
Trends Microbiol; 2008 May; 16(5):222-9. PubMed ID: 18394902
[TBL] [Abstract][Full Text] [Related]
36. Structural organization of the functional domains of Clostridium difficile toxins A and B.
Pruitt RN; Chambers MG; Ng KK; Ohi MD; Lacy DB
Proc Natl Acad Sci U S A; 2010 Jul; 107(30):13467-72. PubMed ID: 20624955
[TBL] [Abstract][Full Text] [Related]
37. Four distinct structural domains in Clostridium difficile toxin B visualized using SAXS.
Albesa-Jové D; Bertrand T; Carpenter EP; Swain GV; Lim J; Zhang J; Haire LF; Vasisht N; Braun V; Lange A; von Eichel-Streiber C; Svergun DI; Fairweather NF; Brown KA
J Mol Biol; 2010 Mar; 396(5):1260-70. PubMed ID: 20070948
[TBL] [Abstract][Full Text] [Related]
38. Autoproteolytic activation of bacterial toxins.
Shen A
Toxins (Basel); 2010 May; 2(5):963-77. PubMed ID: 22069620
[TBL] [Abstract][Full Text] [Related]
39. Self-cutting to kill: new insights into the processing of Clostridium difficile toxins.
Aktories K
ACS Chem Biol; 2007 Apr; 2(4):228-30. PubMed ID: 17455899
[TBL] [Abstract][Full Text] [Related]
40. Rational design of inhibitors and activity-based probes targeting Clostridium difficile virulence factor TcdB.
Puri AW; Lupardus PJ; Deu E; Albrow VE; Garcia KC; Bogyo M; Shen A
Chem Biol; 2010 Nov; 17(11):1201-11. PubMed ID: 21095570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
